HDAC inhibition may reverse anthracycline resistance in patients with sarcomaMarch 3, 2016Sarcoma & GIST
IDH1 mutant inhibitor targets gliomas, chondrosarcomasNovember 16, 2015Sarcoma & GISTCNS/Brain Cancer
Experimental LOXO-101 induces regression in several hard-to-treat cancersNovember 10, 2015Sarcoma & GISTLung CancerHead & Neck/Thyroid Cancers
Adjuvant imatinib for 3 years better than 1 year in high-risk GISTNovember 2, 2015GastroenterologySarcoma & GISTGastrointestinal Cancer
Dose-intensive, multiagent regimen improves outcomes from low-risk rhabdomyosarcomaOctober 26, 2015Sarcoma & GISTRare Diseases
FDA approves trabectedin for some advanced soft tissue sarcomasOctober 23, 2015Sarcoma & GISTRare Diseases
Trabectedin superior for advanced liposarcoma, leiomyosarcomaSeptember 18, 2015Sarcoma & GISTRare Diseases
Long-term follow-up shows 22% survival rate for advanced GISTJune 6, 2014GastroenterologySarcoma & GISTGastrointestinal Cancer
Launch of rare-cancer trial spurs many more April 4, 2014Gynecologic CancerRare DiseasesSarcoma & GIST
The push for smaller, smarter cancer trialsMarch 17, 2014Breast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
